ASH Meeting on Hematologic Malignancies
September 10 - 11, 2021
ASH is continually re-assessing the status of our upcoming meetings in light of the COVID-19 pandemic. We encourage you to monitor our various meetings webpages to stay abreast of the latest updates.
The ASH Meeting on Hematologic Malignancies features the top experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues – all through a virtual experience. Participation in the 2021 meeting will provide participants an opportunity to hear experts present cutting-edge scientific data, provide out-of-the-box treatment approaches, and answer challenging patient care questions during topic-based panel discussions.
Program content will be structured as “How I Treat” presentations that showcase each speaker’s evidence-based treatment approaches. Attendees will learn how new data can be translated into new strategies for diagnosis and treatment, find out what to do in cases where this no data, and gain knowledge that can help make immediate impacts on their practice.
Hear exciting updates in each of the core malignancies, including:
- Myelodysplastic syndromes
- Myeloproliferative neoplasms